Schedule 13D ownership disclosure
EVOKE PHARMA INC
Security class unavailable · CUSIP: 30049G203
Event date: 2024-09-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-104983
- Form type
- SC 13D
- Filer
- Evoke Pharma Inc
- CIK
- CIK 1403708
- Filed
- Oct 01, 2024
- Reporting period
- Sep 27, 2024
- Description
- Schedule 13D beneficial ownership